Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 2014

View Archived Issues

Hydrogel-based inhibitor delivery system developed to prevent adverse cardiac remodeling

Roche divulges new agents for HBV infection

Idera Pharmaceuticals reports topline data from phase II trial of IMO-8400

Fujifilm and Center for iPS Cell Research initiate collaboration on T-817MA

Amgen presents new GK-GKRP disruptors for type 2 diabetes

Quidel receives FDA clearance for AmpliVue HSV 1+2 assay

Meridian Biosciences' illumigene Pertussis test cleared by the FDA

FDA committee recommends approval of Cologuard colorectal cancer screening test

Japan Vaccine seeks approval of pediatric pneumococcal conjugate vaccine in Japan

Phase IIb topline results reported for cariprazine in bipolar depression

FDA grants orphan drug status to NHL treatments

Takeda licenses Trianni transgenic mouse antibody discovery platform

Eisai assigns Dacogen rights to Otsuka Pharmaceutical

Janssen Pharmaceutical discloses novel fatty acid synthase inhibitors

New MPS1 inhibitors presented by Cancer Research Technology

Japanese researchers design new MetAP 2 inhibitors

Reata Pharmaceuticals divulges new NO production inhibitors

Bristol-Myers Squibb presents new agent for thrombosis

New agents for dengue virus disclosed by SIGA Technologies

e-Therapeutics reports interim results from phase Ia trial of ETS-2101

CytRx's aldoxorubicin receives orphan medicinal product designation in Europe

GSK withdraws request for a variation to Votrient's marketing authorization

FDA lifts partial clinical hold on CUDC-427

Shire submits Intuniv MAA to EMA

NIH funds flavivirus research at The Scripps Research Institute

FDA advisory committee recommends approval of dalbavancin for ABSSSI

Tedizolid phosphate recommended for FDA approval for skin infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...